-
About 3% of children in the age group authorized last week to get a low-dose vaccine will have their first shots by Wednesday, according to the White House.
-
After the federal Centers for Disease Control and Prevention approved a Pfizer vaccine dose safe for 5 to 11-year-old children against COVID-19, a pediatrician tells WLRN why parents and guardians should take kids in this group to get protected against the disease as soon as possible.
-
The companies say a study of more than 10,000 volunteers showed a vaccine efficacy of 95% or greater for people receiving the booster.
-
Based on the strength of the trial's results, Pfizer says it will ask the FDA for emergency use authorization rather than enroll more people for clinical trials.
-
Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.
-
Moderna says the FDA is looking into reports of a rare side effect — myocarditis, or the inflammation of the heart muscle — in those who've gotten the shot.
-
There are a couple of big steps to get through before U.S. kids under 12 might be able to get the vaccine. Here's how the process works and when the shots could arrive.
-
After some debate, a group of scientists advising the FDA concluded that the vaccine's benefits outweigh its risks for young children.
-
The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.
-
Should people who get a COVID booster get a different vaccine from their original shot? The results of a highly anticipated study suggest that in some cases the answer may be yes.
-
"With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19," the pharmaceutical giant said.
-
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.